CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • vendors

Towards a New World Order

The present-day life sciences industry needs to effectively and swiftly organize the rising volumes of structured and unstructured data from myriad systems such as EMRs into comparable formats, analyze them, and visualize the findings. With standard statistical methodologies like regression, the time taken to analyze all the data takes weeks that negatively impacts the industry in real-time diagnoses and development of precise medicines. In most cases of pre- and post-launch drug failures, improperly designed clinical trials, unsuitable patient population, and lack of competitive differentiation are the main reasons. Analytics-driven insights help the life sciences industry to improve their understanding of clinical trial factors and discover unforeseen patterns that could result in the formulation of new hypotheses for better and more improved medicines. In addition, analytics can significantly accelerate drug discovery and development by mapping patient trends to identify target markets, highlighting gaps in the efficacy and safety of current drugs, and narrowing down on test sites with high patient availability.

Although the the life science industry has experienced various challenges in terms of operations like patent cliffs, approval of generics, growing investments in R&D, and stringent regulatory guidelines and compliances, the use of analytical tools and techniques aid in conquering these challenges related to data integration. Some of the key applications of data analytics, including product enablement, marketing support, regulatory compliance reporting, sales support, and data integration assist the industry in adopting digital records for maintaining high standards and sophistication apart from committing minimal errors. Besides, innovative technologies like AI, machine learning, national language processing (NLP) are being used to improve the operations in producing new medicines, to connect better with the patients and understand their needs, and further enhance their sales and marketing functions. These technologies, combined with various analytics tools, facilitate sales executives in quickly sharing information with physicians, developing tailored messages, and more meaningful interactions with patients.

While AI can help drug makers to create new and improved treatments and find ways to get patients’ access to treatment immediately, machine learning algorithms easily classify compounds that have similar effects together and passes on the clean data to drug makers. Moreover, the NLP solutions can detect information like previous research documents within unstructured data that may add value to the drug discovery process.

Today, the life science industry needs to reduce healthcare costs, improve patient outcomes, and enable access to health information for profitable business and better customer experience. And, to assist this industry in taking advantage of the emerging technologies in life sciences analytics, the upcoming edition of Life Sciences Review features a list of leading vendors along with insightful articles from thought leaders in the life sciences analytics arena.

Let us know your thoughts!

Towards a New World Order Embracing Growth with Digital Advancements The Next Stage of Life Sciences Evolution

Nominate a Company

Our subscribers nominate the companies with whom they have collaborated and gotten results. If you think there is a company that deserves to be on our upcoming prestigious annual list of Towards a New World Order , please write to us about them and the reasons you think they need to be on the list

* 

Thank You!

checkmark

Your nomination request for upcoming annual list of "Towards a New World Order" has been Successfully Sent . We will be in touch with you shortly.

Data not inserted

Towards a New World Order

Bioelectronica

Bioelectronica

VIEW PROFILE

A research-stage biotechnology company building next-generation digital tools for drug discovery, diagnostics, and cell sorting. The company is one of the leading entities using the advances behind Moore’s law and passing those benefits on to biochemists. Bioelectronica invented “electrofluidic chips,” which are built through planar processes to solve a core problem in biochemistry and cell biology: manipulating small (nanoliter) volume of liquids and detecting chemical or biochemical reactions inside them. This is an inexorable advancement for drug developers and other cell biologists as electrofluidic chips are scalable to billions of nanopore channels, which can be used to transport and sort single cells based on their secretion rate and other properties

I have always felt that a key part of technology is decentralizing advanced technologies

—Dr. Jonathan Hull, Co-Founder and Vice President and Roger Chen, Founder and President

Bioelectronica

Visit vendor website

Management
Dr. Jonathan Hull, Co-Founder and Vice President and Roger Chen, Founder and President

DATABASICS

DATABASICS

VIEW PROFILE

Provides cloud-based, next-generation expense reporting, timesheet management, and invoice processing automation

With DATABASICS Expense, sales and marketing people can record individual HCP expenditures, assign the proper NPI, and extract associated HCP personal information

Marcel Syriani, CTO

DATABASICS

Visit vendor website

Management
Marcel Syriani, CTO

Medimix International

Medimix International

VIEW PROFILE

Leveraging real-world evidence to generate actionable insights that help pharmaceutical, diagnostic, and medical device companies better understand drug performance. Medimix International has created a cloud-based, real-time tracker called LiveTracker™. The real-time product performance solution helps pharmaceutical firms to get a better understanding of the effectiveness of their drugs by monitoring and reporting on the patient journey, physicians’ preference on the product, awareness of the product in the market, and other key aspects. LiveTracker™ currently provides trustworthy RWE on areas including treatment outcomes, patient profiles, and market structure, in over 60 countries

Using this single source of information that is updated on a monthly basis, pharma companies seamlessly compare the usage and efficiency of their drugs across multiple regions

—Henry Gazay, CEO

Medimix International

Visit vendor website

Management
Henry Gazay, CEO

RCM Technologies

RCM Technologies

VIEW PROFILE

RCM Technologies, Inc. (NasdaqGM: RCMT) is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering and information technology services. RCM is also a provider of specialty health care services to major health care institutions and educational facilities. RCM has been an innovative leader in the design, development, and delivery of these services to commercial and government sectors for over 35 years. Over the years, the Company has developed and assembled an attractive, diverse and extensive portfolio of capabilities, service offerings and delivery options, established a proven record of performance and credibility, and built an efficient pricing structure

We bring in our extensive breadth of knowledge and unique capabilities to cater to the technology, engineering, staffing, and regulatory requirements—all under one roof

—William Gargano, SVP

RCM Technologies

Visit vendor website

Management
William Gargano, SVP

Magazine

Other 2021

Top Vendors

Towards a New World Order

Other 2020

Top Vendors

The Next Stage of Life Sciences Evolution

Other 2020

Top Vendors

Embracing Growth with Digital Advancements

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/vendors/towards-a-new-world-order.html